Publication | Open Access
Usefulness of <sup>18</sup>F‐fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma
37
Citations
26
References
2020
Year
PERCIST was more accurate in determining NAT's therapeutic effects for PDAC than RECIST. MTV reduction rates were independent prognostic factors for PDAC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1